110
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Tripartite siRNA micelles as controlled delivery systems for primary dendritic cells

, , , , , , & show all
Pages 950-958 | Received 15 Nov 2008, Accepted 30 Dec 2008, Published online: 19 May 2009

References

  • Napoli C, Lemieux C, Jorgensen R. (1990). Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell, 2:279–89.
  • Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorrhabditis elegans. Nature, 391:806–10.
  • Li C, Parker XA, Menocal E, Xiang S, Borodyansky L, Fruehauf JH. (2006). Delivery of RNA interference. Cell Cycle, 5:2103–9.
  • Akhtar S, Benter IF. (2007). Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest, 117:3623–32.
  • Zhang S, Zhao B, Jiang H, Wang B, Ma B. (2007). Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release, 123:1–10.
  • Nishiyama N, Kataoka K. (2006). Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Therapeut, 112:630–48.
  • Oishi M, Hayama T, Akiyama Y, Takae S, Harada A, Yamasaki Y, (2005). Supramolecular assemblies for the cytoplasmic delivery of antisense oligonucleotide: Polyion complex (PIC) micelles based on poly(ethyleneglycol)-SS-oligonucleotide conjugate. Biomacromolecules, 6:2449–54.
  • Lavasanifar A, Samuel J, Kwon GS. (2002). Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev, 54:169–90.
  • Kakizawa Y, Kataoka K. (2002). Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev, 54:203–22.
  • Boudier A, Aubert-Pouëssel A, Louis-Plence P, Gérardin C, Jorgensen C, Devoisselle J-M, (2009). The control of the dendritic cell maturation by pH-sensitive polyion complex micelles. Biomaterials, 30:233–41.
  • Hart D. (1997). Dendritic cells: Unique leucocyte populations which control the primary immune response. Blood, 90:3245–87.
  • Steinman R, Banchereau J. (2007). Taking dendritic cells into medicine. Nature, 449:419–26.
  • Hill JA, Ichim TE, Kusznieruk KP, Li M, Huang X, Yan X, (2003). Immune modulation by silencing Il-12 production in dendritic cells using small interfering RNA. J Immunol, 171:691–6.
  • Li M, Zhang X, Zheng X, Lian D, Zhang ZX, Ge W, (2007). Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol, 178:5480–7.
  • Charbonnier L-M, Van Duivenvoorde LM, Apparailly F, Cantos C, Han WGH, Noël D, (2006). Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J Immunol, 177:3806–13.
  • Katas H, Alpar HO. (2006). Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release, 115:216–25.
  • Förster T. (1959). Transfer mechanisms of electronic excitation. Discuss Faraday Soc, 27:7–17.
  • Yessine M-A, Leroux J-C. (2004). Membrane-destabilizing polyanions: Interaction with lipid bilayers and endosomal escape of biomacromolecules. Adv Drug Deliv Rev, 56:999–1021.
  • Kalyanasundaram K, Thomas JK. (1977). Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J Am Chem Soc, 99:2039–44.
  • Lochmüller CH, Wenzel TJJ. (1990). Spectroscopic studies of pyrene at silica interfaces. J Phys Chem, 94:4230–5.
  • Holappa S, Andersson T, Kantonen L, Plattner P, Tenhu H. (2003). Soluble polyelectrolyte complexes composed of poly(ethylene oxide)-blockpoly (sodium methacrylate) and poly(methacryloyloxyethyl trimethylammonium chloride). Polymer, 44:7907–16.
  • Yessine M-A, Lafleur M, Meier C, Petereit H-U, Leroux J-C. (2003). Characterization of the membrane-destabilizing properties of different pH-sensitive methacrylic acid copolymers. Biochim Biophys Acta, 1613:28–38.
  • Hu Y, Litwin T, Nagaraja AR, Kwong B, Katz J, Watson N, (2007). Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett, 7:3056–64.
  • Banchereau J, Palucka KA. (2005). Dendritic cells as therapeutic vaccines against cancer. Nature, 5:296–306.
  • Kim WT, Lee JH, He L, Boyd DAK, Hardwick JM, Hung C-F, (2005). Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. Cancer Res, 65:309–16.
  • Suzuki M, Zheng X, Zhang X, Li M, Vladau C, Ichim TE, (2008). Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J Immunol, 180:8461–9.
  • Van Duivenvoorde LM, Van Mierlo GJD, Boonman ZFHM, Toes REM. (2006). Dendritic cells: Vehicles for tolerance induction and prevention of autoimmune diseases. Immunobiology, 211:627–32.
  • Van Der Burgh S, De Keizer A, Cohen Stuart MA. (2004). Complex coacervation core micelles. Colloidal stability and aggregation mechanism. Langmuir, 20:1073–84.
  • Yessine M-A, Dufresne M-H, Meier C, Petereit H-U, Leroux J-C. (2007). Proton-actuated membrane-destabilizing polyion complex micelles. Bioconjug Chem, 18:1010–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.